These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22118882)

  • 1. Intravenous thrombolysis in Sneddon's syndrome.
    Sun J; Zhang F; Gao F; Wang J; Selim M; Lou M
    J Clin Neurosci; 2012 Feb; 19(2):326-8. PubMed ID: 22118882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sneddon's syndrome: a case report.
    Lahti J; Yu T; Burnett JW; Lutz L; LaMonte MP; Gunawardane R
    Cutis; 2001 Mar; 67(3):211-4, 220. PubMed ID: 11270293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the kidney lesion in a patient with Sneddon's syndrome].
    Kirsanova TV; Kozlovskaia NL; Kalashnikova LA; Smirnova TV; Roshchupkina SV; Khafizova EIu
    Ter Arkh; 2009; 81(8):73-7. PubMed ID: 19799206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Sneddon's syndrome.
    Mascarenhas R; Santo G; Gonçalo M; Ferro MA; Tellechea O; Figueiredo A
    Eur J Dermatol; 2003; 13(3):283-7. PubMed ID: 12804991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sneddon's syndrome: 4 cases and a review of the literature].
    Abouzahir A; Bourazza A; Rafik R; Karouach K; Boutaleb N; Ouhabi H; Mosseddaq R; Ohayon V; Archane MI
    Rev Neurol (Paris); 2003 Dec; 159(12):1156-62. PubMed ID: 14978416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral haemorrhage in Sneddon's syndrome: case report and literature review].
    Serrano-Pozo A; Gómez-Aranda F; Franco-Macías E; Serrano-Cabrera A
    Rev Neurol; 2004 Oct 16-31; 39(8):731-3. PubMed ID: 15514901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid-negative Sneddon's syndrome: A comprehensive overview of a rare entity.
    Assan F; Bottin L; Francès C; Moguelet P; Tavolaro S; Barbaud A; de Zuttere D; Alamowitch S; Chasset F
    Ann Dermatol Venereol; 2022 Mar; 149(1):3-13. PubMed ID: 34740467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sneddon's syndrome: another migraine-stroke association?
    Tietjen GE; Al-Qasmi MM; Gunda P; Herial NA
    Cephalalgia; 2006 Mar; 26(3):225-32. PubMed ID: 16472327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sneddon's syndrome and antithrombin III.
    Bolayir E; Keçeci H; Akyol M; Taş A; Polat M
    J Dermatol; 1999 Aug; 26(8):532-4. PubMed ID: 10487010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of Sneddon's syndrome.
    Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D
    Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, neurovascular and neuropathological features in Sneddon's syndrome.
    Marinho JL; Piovesan EJ; Leite Neto MP; Kotze LR; Noronha Ld; Twardowschy CA; Lange MC; Scola RH; Zétola VH; Nóvak EM; Werneck LC
    Arq Neuropsiquiatr; 2007 Jun; 65(2B):390-5. PubMed ID: 17665002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sneddon's syndrome: case report and review of its relationship with antiphospholipid syndrome.
    Dutra LA; Braga-Neto P; Pedroso JL; Barsottini OG
    Einstein (Sao Paulo); 2012; 10(2):230-2. PubMed ID: 23052460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sneddon Syndrome and antiphospholipid antibodyies: an etiology of later al homonymous hemianopia].
    Kriet M; Fiqhi A; Bouya Y; Louaya S; Laktaoui A
    Bull Soc Belge Ophtalmol; 2010; (316):43-7. PubMed ID: 21309142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral haemorrhage as the presenting form of Sneddon's syndrome.
    Kraemer M; Berlit P
    Clin Neurol Neurosurg; 2008 May; 110(5):533. PubMed ID: 18367321
    [No Abstract]   [Full Text] [Related]  

  • 18. Sneddon's syndrome: a cause of cognitive decline in young adults.
    Adair JC; Digre KB; Swanda RM; Hartshorne MF; Lee RR; Constantino TM; Knoefel JE
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(3):197-204. PubMed ID: 11513104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
    Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
    No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.